Skip to content

Celanese Corporation CE Trading Securities in Marketable Securities

Trading Securities in Marketable Securities at other companies

Dow logo
DowDOW

Segments

By segment

See full
Acetyl Chain$165M0.0%
Corporate and Other$5M0.0%

Other financials

Income statement

See full
Revenue$2.3B-2.2%
Gross profit$468.0M-1.3%
Operating income$214.0M+29.7%
Net income$44.0M+283%
EPS (diluted)$0.40+282%

Balance sheet

See full
Cash & equivalents$1.8B+84.9%
Total debt$14.8B+12.2%
Total equity$4.1B-20.9%
Total assets$21.7B-6.3%

Cash flow

See full
Operating cash flow$76.0M+105%
CapEx$66.0M-35.3%
Free cash flow$10.0M+115%

Valuation

See full
Market cap$5.61B+16.0%
Enterprise value$18.61B+9.8%
P/S0.6×+0.1×

Profitability

See full
Gross margin20.5%-2.0pp
Operating margin-23.7%-32.7pp
Net margin-11.7%-2.7pp
FCF margin9.2%+4.2pp

Returns & leverage

See full
Return on equity-24.2%-2.6pp
Debt / equity3.6×+1.1×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Celanese Corporation in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: Celanese Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celanese Corporation's trading securities in marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celanese Corporation's trading securities in marketable securities?
Celanese Corporation (CE) reported trading securities in marketable securities of $170M in Q1 2026.
How has Celanese Corporation's trading securities in marketable securities changed year-over-year?
Celanese Corporation's trading securities in marketable securities decreased by 0.0% year-over-year, from $170M to $170M.
What is the long-term trend for Celanese Corporation's trading securities in marketable securities?
Over 5 years (2020 to 2025), Celanese Corporation's trading securities in marketable securities has grown at a -0.1% compound annual growth rate (CAGR), from $171M to $170M.